SCHEMBL8986956

SCHEMBL8986956

CCC(C)(C)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
CYP4F2 P78329 3/20 0.41
CYP4A11 Q02928 3/20 0.41
THRB P10828 3/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 5/20 0.39
MAPK1 P28482 2/20 0.39
ALDH1A1 P00352 5/20 0.38
EPHX2 P34913 1/20 0.33
TP53 P04637 2/20 0.32
HIF1A Q16665 2/20 0.32
HSD17B10 Q99714 1/20 0.32
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
CASP1 P29466 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SLCO1B3 Q9NPD5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12200878 1.00 MEN1 (0.42) MEN1KMT2ACYP4F2CYP4A11THRB
SCHEMBL18219829 1.00 MEN1 (0.42) MEN1KMT2ACYP4F2CYP4A11THRB
SCHEMBL18219827 1.00 MEN1 (0.42) MEN1KMT2ACYP4F2CYP4A11THRB
SCHEMBL8986964 1.00 MEN1 (0.42) MEN1KMT2ACYP4F2CYP4A11THRB
SCHEMBL118142 1.00 MEN1 (0.42) MEN1KMT2ACYP4F2CYP4A11THRB
SCHEMBL117040 1.00 MEN1 (0.42) MEN1KMT2ACYP4F2CYP4A11THRB
SCHEMBL12200888 1.00 MEN1 (0.42) MEN1KMT2ACYP4F2CYP4A11THRB
SCHEMBL11941092 1.00 MEN1 (0.42) MEN1KMT2ACYP4F2CYP4A11THRB
SCHEMBL12126252 1.00 MEN1 (0.42) MEN1KMT2ACYP4F2CYP4A11THRB
SCHEMBL10089273 0.89 CYP4F2 (0.49) MEN1KMT2ACYP4F2CYP4A11THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188204-B2 Polymers, compositions and methods for use for foams, laundry detergents, shower rinses and coagulants RHODIA INC. (US) 2012-05-29 US disclosed
US-20110257015-A1 POLYMERS, COMPOSITIONS AND METHODS FOR USE FOR FOAMS, LAUNDRY DETERGENTS, SHOWER RINSES AND COAGULANTS RHODIA INC. (US) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257015-A1 POLYMERS, COMPOSITIONS AND METHODS FOR USE FOR FOAMS, LAUNDRY DETERGENTS, SHOWER RINSES AND COAGULANTS DSG1, DSTN, TES MEN1 3703/4885KMT2A 2298/4885CYP4F2 4398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.